Publicaties T. Veninga

2010



Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC)
(G. Bohlen, T. Meyners, S. Kieckebusch, R. Lohynska, T. Veninga, et al) Clin Neurol Neurosurg, 2010; 112: 183-187.

pubmed
First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II.
(D. De Ruysscher, D. Severin, E. Barnes, M. Baumann, R. Bristow, et al) Radiother Oncol 2010. [geaccepteerd voor publicatie]

pubmed
Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression.
(D. Rades, S. Douglas, T. Veninga, L.J. Stalpers, P.J. Hoskin, et al) Cancer 2010; 116:3670-3673.

pubmed
Scoring Systems to Estimate Intracerebral Control and Survival Rates of Patients Irradiated for Brain Metastases.
(D. Rades, L. Dziggel, T. Haatanen, T. Veninga, R. Lohynska, et al) Int J Radiat Oncol Biol Phys 2010. [geaccepteerd voor publicatie]

pubmed
Validation of a Score Predicting Post-Treatment Ambulatory Status After Radiotherapy for Metastatic Spinal Cord Compression.
(D. Rades, S. Douglas, S. Huttenlocher, V. Rudat, T. Veninga, et al) Int J Radiat Oncol Biol Phys 2010. [geaccepteerd voor publicatie]

pubmed
Final Results of a Prospective Study Comparing the Local Control of Short-course and Long-course Radiotherapy for Metastatic Spinal Cord Compression.
(D. Rades, M. Lange, T. Veninga, L.J. Stalpers, A. Bajrovic, I.A. Adamietz, V. Rudat, S.E. Schild) Int J Radiat Oncol Biol Phys 2010. [geaccepteerd voor publicatie]

pubmed




2009



Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
(K. Gehring, M.M. Sitskoorn, C.M. Gundy, S.A. Sikkes, M. Klein, et al) J Clin Oncol 2009; 27: 3712-3722.

pubmed
Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression.
(D. Rades, M. Lange, T. Veninga, V. Rudat, A. Bajrovic, et al) Int J Radiat Oncol Biol Phys 2009; 73: 228-234.

pubmed
A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
(D. Rades, J.D. Kueter, A. Pluemer, T. Veninga, S.E. Schild) Int J Radiat Oncol Biol Phys 2009; 73: 1077-1081.

pubmed
Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matched pair analysis.
(D. Rades, J.D. Kueter, T. Veninga, J. Gliemroth, S.E. Schild) Eur J Cancer 2009; 45: 400-404.

pubmed
Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.
(D. Rades, D. Fischer, T. Veninga, L.J. Stalpers, S.E. Schild) Gynecol Oncol 2009; 114: 506-508.

pubmed




2008



Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
(D. Pasquier, S. Bijmolt, T. Veninga, N. Rezvoy, S. Villa, et al) Int J Radiat Oncol Biol Phys 2008; 71: 1388-1393.

pubmed
Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
(D. Rades, G. Bohlen, J. Dunst, R. Lohynska, T. Veninga, et al) Strahlenther Onkol 2008; 184: 30-35.

pubmed
A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.
(D. Rades, V. Rudat, T. Veninga, L.J. Stalpers, H. Basic, et al) Int J Radiat Oncol Biol Phys 2008; 72: 905-908.

pubmed
Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
(D. Rades, V. Rudat, T. Veninga, L.J. Stalpers, P.J. Hoskin, et al) Cancer 2008; 113: 1090-1096.

pubmed
Comparison of different treatment approaches for one to two brain metastases in elderly patients.
(D. Rades, A. Pluemer, T. Veninga, S.E. Schild) Strahlenther Onkol 2008; 184: 565-571.

pubmed
Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.
(D. Rades, J.D. Kueter, D. Hornung, T. Veninga, P. Hanssens, et al) Strahlenther Onkol 2008; 184: 655-662.





2007



Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases.
(D. Rades, T. Veninga, L.J. Stalpers, H. Basic, et al.) J Clin Oncol 2007; 25: 50-56.

pubmed
Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
(D. Rades, G. Bohlen, A. Pluemer, T. Veninga, P. Hanssens, et al.) Cancer 2007; 109: 2515-2521.

pubmed
Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression.
(D. Rades, T. Veninga, L.J. Stalpers, H. Basic, et al.) Int J Radiat Oncol Biol Phys 2007; 67: 1506-1509.

pubmed
Radiotherapy of metastatic spinal cord compression in very elderly patients.
(D. Rades, P.J. Hoskin PJ, J.H. Karstens, V. Rudat, T. Veninga, et al.) Int J Radiat Oncol Biol Phys 2007; 67: 256-263.

pubmed
Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
(D. Rades, J.H. Karstens, P.J. Hoskin, V. Rudat, T. Veninga, et al.) Int J Radiat Oncol Biol Phys 2007; 67: 525-531.

pubmed
Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
(D. Rades, F. Fehlauer, T. Veninga, L.J. Stalpers, H. Basic, et al.) Int J Radiat Oncol Biol Phys 2007; 67: 532-537.

pubmed
Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone?
(D. Rades, J. Walz, S.E. Schild, T. Veninga, J. Dunst) Urology 2007; 69: 1081-1085.

pubmed
Two radiation regimens and prognostic factors for brain metastases in non-small cell lung cancer patients.
(D. Rades, S.E. Schild, R. Lohynska, T. Veninga, L.J. Stalpers, J. Dunst) Cancer 2007; 110: 1077-1082.

pubmed
A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
(D. Rades, A. Pluemer, T. Veninga, J. Dunst, S.E. Schild) Cancer 2007; 110: 1551-1559.

pubmed
Reduction of overall treatment time in patients irradiated for more than three brain metastases.
(D. Rades, S. Kieckebusch, R. Lohynska, T. Veninga, L.J. Stalpers, et al.) Int J Radiat Oncol Biol Phys 2007; 69: 1509-1513.

pubmed
Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
(D. Rades, R. Lohynska, T. Veninga, L.J. Stalpers, S.E. Schild) Cancer 2007; 110: 2587-2592.

pubmed
Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
(D. Rades, A. Pluemer, T. Veninga, P. Hanssens, J. Dunst, S.E. Schild) Cancer 2007; 110: 2285-2292.

pubmed
Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
(D. Rades, G. Bohlen, R. Lohynska, T. Veninga, L.J. Stalpers, et al) Strahlenther Onkol 2007; 183: 631-636.

pubmed

Printen